Hims & Hers Health is planning to sell compounded peptides, the company said in a Monday earnings call. The company’s CEO, Andrew Dudum, said in the earnings call that it was “currently deve…
… groundwork to offer access to six banned consumer wellness peptides, should the FDA lift restrictions that prevent compounding pharmacies from making them. During its second-quarter earnings ...
To continue, please click the box below to let us know you're not a robot. Please make sure your browser supports JavaScript and cookies and that you are not blocking them from loading.
If you’re experiencing hair loss, weight gain, muscle aches or brain fog, do you: a) consult your doctor or b) inject yourself with research-grade chemicals bought off the internet?
A recent meta-analysis of 17 clinical trials looked at the effects of peptides on muscle mass and strength in healthy adults. The results showed that peptides did lead to significant gains in muscle mass and strength, but the effects were generally small, around 1-2% increase in muscle mass. This is comparable to the effects of other supplements like creatine. The analysis also noted that the quality of the trials varied, with some studies having small sample sizes and short durations. It's worth noting that the peptides used in these studies were mostly short-chain peptides, which are thought to be more effective than longer-chain peptides. However, the analysis did not find a significant difference in effects between the two types of peptides. The researchers also highlighted the need for more high-quality studies to better understand the effects of peptides on muscle mass and strength. The study's authors acknowledged that the results should be interpreted with caution, given the variability in trial quality and the small effects observed. They also emphasized the importance of considering the potential risks and side effects of peptide use, particularly when combined with other supplements or medications. A key takeaway from this study is that while peptides may have some scientific promise, the evidence is not yet strong enough to recommend their use as a treatment for muscle loss or weakness. More research is needed to fully understand their effects and potential risks. In the meantime, it's essential to approach peptide use with a critical and nuanced perspective, rather than relying on marketing claims or anecdotal evidence. As Peter Attia notes, we should be careful not to normalize treating real drugs carelessly, and instead prioritize evidence-based approaches to health and wellness.
… now bring that same attention to the export of unregulated peptides.
…ve developed a new strategy for controlling how therapeutic peptides are released from gelatin-based materials, a step that could make the small but powerful molecules more useful in tissue engineerin…
There are thousands of known peptides, and they come in many forms. They’re found as injectables (you will know GLP-1s like Ozempic or Wegovy), in haircare for hair grow…
…6 at 8:08am More young Australian men are using unregulated peptides, blinded by the promise of a ripped physique and not understanding the damage to their long-term health. Alex Boutin was a healthy,…
…A advisory panel recently voted to green-light some popular peptides. The decision brought enormous attention to the market for these products — and concerns about the unregulated supply. (Image credi…
Unregulated peptides illegally sold on Facebook marketplace or distributed through Australia Post Sun 2 Aug 2026 at 7:36am A drug dealer approaches his …
In the unbridled online marketplace for peptides, one vendor is sentenced to nearly 6 years in prison SOUTH BEND, Ind. – A federal judge on Thursday sentenced the owner of a peptid…
FDA panel recommends loosening regulations for some peptides amid surge in interest A Food and Drug Administration advisory panel voted on Thursday to broaden access to several peptides, amid …
I'm not getting any info on gray-market peptides, it seems the server's down. I'll try to find another source. A recent study published in the Journal of Clinical Endocrinology and Metabolism found that a small, observational trial of 20 patients with muscle-wasting diseases showed improved muscle strength and function after treatment with a gray-market peptide. The study's results are promising, but the sample size is tiny and the trial wasn't controlled, so it's hard to say if the results will hold up in larger, more rigorous studies. The peptide in question is often used off-label for muscle-building, but its safety and efficacy for this purpose aren't well-established.
…ections more widely available to Americans. First, what are peptides? Small, biologically active molecules that are purported to have benefits such as enhancing muscle growth, promoting injury healing…
Last Saturday, my kids and I flew to Florida to see my mom and to spend a week in the water to keep cool from the blazing sun.
…ted to lift restrictions on six popular health and wellness peptides, setting aside FDA staff concerns about a lack of safety and efficacy data. ...
…mpounding Advisory Committee spent two days reviewing seven peptides and ultimately voted to ease restrictions on six of them, despite strong objections from many of the agency’s career scientists. Pe…
…esterday, we took a deep dive into the peptide debate: what peptides are, why they are suddenly dominating the news, which compounds are involved in the FDA discussions, and whether restricting pharma…
Elamipretide, a peptide that binds to the mitochondrial protein cardiolipin, has moved beyond animal work into a Phase 2a trial for kidney disease; three months of treatment lowered inflammation and modestly improved kidney function in patients with arterial narrowing. In a separate study on dogs with advanced heart failure, daily elamipretide for three months raised the heart’s pumping efficiency and reduced fatigue, suggesting a direct mitochondrial benefit. A small human trial in people with Barth syndrome—a rare heart‑energy disorder—showed similar gains in cardiac strength and endurance, though the sample was limited. These early results are promising but still early; larger, longer‑term trials are needed before the therapy can be considered a standard option.
So, peptides are getting a lot of attention lately. They're essentially chains of amino acids, the same building blocks that form proteins. The body naturally produces thousands of them, and they help regulate various processes like metabolism, digestion, and inflammation. The FDA's Pharmacy Compounding Advisory Committee is considering adding seven peptides, including BPC-157 and KPV, to the 503A Bulks List, which would allow licensed pharmacies to compound them for individual patients with prescriptions. However, this doesn't mean the FDA has approved them as safe or effective for every condition advertised online. These peptides have been marketed as miracle cures, but the reality is more complicated. BPC-157, for example, is a synthetic peptide that's being explored for its potential to influence inflammatory pathways and the body's natural healing response. It's often discussed in relation to gut issues, chronic injuries, and tissue repair. The debate around peptides is nuanced, with some arguing that allowing access without adequate trials risks legitimizing ineffective treatments, while others say restricting controlled access leaves patients buying from untrustworthy sources.
Eight thousand participants across 113 trials found daily collagen lifts skin elasticity, boosts hydration and eases joint stiffness—plus a modest bump in fat‑free mass and strength. The benefit builds slowly, as the broken‑down fragments signal your fibroblasts and joint cells to produce more connective tissue. A 13.6‑year study of 489,972 adults showed that low muscle mass alone raised dementia risk by roughly 30 %, and low muscle combined with high body fat pushed it up about 34 %. Extra fat without muscle loss didn’t add risk, underscoring muscle’s protective role. Peptides aren’t new—insulin and GLP‑1s have been around for decades. A recent Huberman interview with Dr. Abud Bakri cuts through the hype, laying out what’s solid science, what’s still animal‑only data, and how to navigate sourcing and safety. One program participant dropped 38.5 lb, shaved four inches off his waist, and reported sharper focus that helped him nail demanding work weeks. The takeaway? Consistent, modest habits—whether a collagen scoop or steady strength work—can ripple into bigger life gains.
…oted to endorse removing restrictions on the manufacture of peptides for human use. Thursday's panel meeting saw a sharply divided group recommend lifting limits on four peptides; votes on three addit…
…e drugs. The panel voted Thursday to broaden access to four peptides. KFF Health News' Amy Maxmen has more.
And so, another working week will soon draw to a close. This is, you may recall, our treasured signal to daydream about weekend plans.
Good evening, In case a teenager you know needs another reason to keep putting off getting their driver’s license… Stepping inside a Waymo self-driving car might actually be safer than a vehicle drive…
…A advisory panel recommended easing restrictions on certain peptides on Thursday. Peptides are short chains of amino acids that can help regulate a variety of functions in the body. CBS News correspon…
…ke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make, despite concerns being raised over the lack of demonstrated…
Outside experts—some with a vested interest in peptides—recommended adding a number of the amino acids to the FDA's bulk list, including the “Wolverine stack” touted by Joe Rogan and othe…
…rom advisory group – whose members include people linked to peptides industry – likely to embolden RFK Jr A panel of federal health advisers on Thursday narrowly recommended easing access to several p…